{
  "meta": {
    "title": "Coronary_And_Peripheral_Vessel_Disease_Valvular_Heart_Disease",
    "url": "https://brainandscalpel.vercel.app/coronary-and-peripheral-vessel-disease-valvular-heart-disease-ae9ddd43.html",
    "scrapedAt": "2025-11-30T08:49:02.921Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer aspirin, initiate unfractionated heparin, and prepare for immediate fibrinolytic therapy</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer oxygen, nitroglycerin, and morphine, and admit to the intensive care unit for monitoring</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Activate the cardiac catheterization lab for emergent percutaneous coronary intervention (PCI)</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Obtain cardiac biomarkers to confirm myocardial infarction before initiating treatment</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 58-year-old man with a history of hypertension and hyperlipidemia presents to the emergency department with acute onset of severe chest pain radiating to his left arm and jaw. The pain started 30 minutes ago while he was resting. On examination, he is diaphoretic and anxious. Vital signs reveal a blood pressure of 150/90 mm Hg, heart rate of 110 beats per minute, and oxygen saturation of 94% on room air. An electrocardiogram (ECG) shows ST-segment elevation of 3 mm in leads II, III, and aVF with reciprocal ST-segment depression in leads I and aVL.<br>According to the AHA guidelines, what is the most appropriate next step in the management of this patient?</span></p>",
      "unique_key": "DT1295247",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295247,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Symptoms:</strong>\r\n<ul>\r\n<li>Acute severe chest pain radiating to the left arm and jaw</li>\r\n<li>Diaphoresis and anxiety</li>\r\n</ul>\r\n</li>\r\n<li><strong>Vital Signs:</strong>\r\n<ul>\r\n<li>Elevated blood pressure and heart rate</li>\r\n</ul>\r\n</li>\r\n<li><strong>ECG Findings:</strong>\r\n<ul>\r\n<li><strong>ST-segment elevation</strong> of 3 mm in leads II, III, and aVF\r\n<ul>\r\n<li>Indicates <strong>inferior wall myocardial infarction</strong></li>\r\n</ul>\r\n</li>\r\n<li><strong>Reciprocal ST-segment depression</strong> in leads I and aVL</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>AHA Guidelines for STEMI Management:</strong></p>\r\n<ul>\r\n<li><strong>Diagnosis of STEMI:</strong>\r\n<ul>\r\n<li>New ST-segment elevation at the J-point in two contiguous leads:\r\n<ul>\r\n<li>&ge;1 mm in all leads other than leads V2-V3</li>\r\n<li>In leads V2-V3:\r\n<ul>\r\n<li>&ge;2 mm in men &ge;40 years</li>\r\n<li>&ge;1.5 mm in women</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li><strong>Immediate Goals</strong>:\r\n<ul>\r\n<li>Rapid reperfusion therapy to restore coronary blood flow</li>\r\n<li>Time is myocardium (\"Time is muscle\")</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Management Options:</strong></p>\r\n<ol>\r\n<li><strong>Emergent Percutaneous Coronary Intervention (PCI):</strong>\r\n<ul>\r\n<li><strong>Preferred Reperfusion Strategy:</strong>\r\n<ul>\r\n<li>PCI is superior to fibrinolytic therapy when performed in a timely manner by experienced operators.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li><strong>AHA Recommendations:</strong>\r\n<ul>\r\n<li><strong>First Medical Contact (FMC)-to-Balloon Time: Within 90 minutes</strong></li>\r\n<li><strong>Indicated for:</strong>\r\n<ul>\r\n<li>STEMI patients presenting within 12 hours of symptom onset</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li><strong>Benefits:</strong>\r\n<ul>\r\n<li>Higher rates of infarct artery patency</li>\r\n<li>Lower risk of hemorrhagic complications</li>\r\n<li>Improved survival rates</li>\r\n</ul>\r\n</li>\r\n<li><strong>Fibrinolytic Therapy:</strong>\r\n<ul>\r\n<li><strong>Indications:</strong>\r\n<ul>\r\n<li>When PCI is not available within 120 minutes of FMC</li>\r\n<li>Administered within 30 minutes of hospital arrival</li>\r\n</ul>\r\n</li>\r\n<li><strong>Limitations:</strong>\r\n<ul>\r\n<li>Higher risk of bleeding</li>\r\n<li>Less effective in achieving complete reperfusion</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n</ol>\r\n<p><strong>Evaluation of Options:</strong></p>\r\n<ul>\r\n<li><strong>Option A:</strong> Administer aspirin, initiate unfractionated heparin, and prepare for immediate fibrinolytic therapy\r\n<ul>\r\n<li><strong>Incorrect,</strong> because PCI is preferred over fibrinolytics if it can be performed within 90 minutes.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Option B:</strong> Administer oxygen, nitroglycerin, and morphine, and admit to the ICU\r\n<ul>\r\n<li><strong>Incomplete,</strong> as it lacks activation of reperfusion therapy, which is critical.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Option C:</strong> Activate the cardiac catheterization lab for emergent PCI\r\n<ul>\r\n<li><strong>Correct,</strong> aligns with AHA guidelines for timely reperfusion.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Option D:</strong> Obtain cardiac biomarkers before initiating treatment\r\n<ul>\r\n<li><strong>Incorrect,</strong> do not delay reperfusion therapy awaiting biomarker results.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Option E:</strong> Start beta-blocker therapy and schedule elective angiography\r\n<ul>\r\n<li><strong>Incorrect,</strong> delays urgent reperfusion therapy.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Conclusion:</strong></p>\r\n<ul>\r\n<li>The patient meets the criteria for STEMI and is within the 12-hour window for reperfusion therapy.</li>\r\n<li>Emergent PCI is available and preferred over fibrinolytics.</li>\r\n<li><strong>Activating the cardiac catheterization lab for emergent PCI is the most appropriate next step.</strong></li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Emergent PCI is the preferred reperfusion strategy</strong> for STEMI if it can be performed within 90 minutes of first medical contact.</li>\r\n<li><strong>Do not delay reperfusion therapy</strong> awaiting cardiac biomarkers if STEMI criteria are met on ECG.</li>\r\n<li><strong>Time-sensitive intervention</strong> is crucial to improve outcomes in STEMI patients.</li>\r\n</ul>\r\n",
      "correct_choice_id": 3,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Arrange immediate transfer to a PCI-capable facility for primary PCI</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer fibrinolytic therapy immediately</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Start medical management with antiplatelet and anticoagulant agents only</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer nitrates and morphine, and observe for symptom resolution</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 62-year-old woman presents with chest pain that started two hours ago. Her ECG shows 2 mm ST-segment elevation in leads V1-V4. She has no contraindications to medications. The nearest PCI-capable facility is three hours away. According to AHA guidelines, which of the following is the best next step?</span></p>",
      "unique_key": "DT1295252",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295252,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Clinical Presentation Analysis:</strong></p>\r\n<ul>\r\n<li><strong>Symptoms:</strong>\r\n<ul>\r\n<li>Chest pain started two hours ago</li>\r\n</ul>\r\n</li>\r\n<li><strong>ECG Findings:</strong>\r\n<ul>\r\n<li>ST-segment elevation in leads V1-V4\r\n<ul>\r\n<li>Indicates <strong>anterior wall myocardial infarction</strong></li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li><strong>Logistical Considerations:</strong>\r\n<ul>\r\n<li>PCI-capable facility is <strong>three hours away</strong></li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>AHA Guidelines for Reperfusion Therapy:</strong></p>\r\n<ul>\r\n<li><strong>Time from Symptom Onset:</strong>\r\n<ul>\r\n<li>Reperfusion therapy is most beneficial when performed early.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Preferred Reperfusion Strategy:</strong>\r\n<ul>\r\n<li><strong>Primary PCI</strong> if it can be performed <strong>within 120 minutes</strong> of first medical contact.</li>\r\n</ul>\r\n</li>\r\n<li><strong>When PCI is Delayed:</strong>\r\n<ul>\r\n<li><strong>If anticipated delay to PCI is over 120 minutes, fibrinolytic therapy should be administered within 30 minutes</strong> of hospital arrival.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Evaluation of Options:</strong></p>\r\n<ul>\r\n<li><strong>Option A:</strong> Arrange immediate transfer to a PCI-capable facility\r\n<ul>\r\n<li><strong>Incorrect,</strong> as transfer would cause a significant delay (&gt;120 minutes).</li>\r\n</ul>\r\n</li>\r\n<li><strong>Option B:</strong> Administer fibrinolytic therapy immediately\r\n<ul>\r\n<li><strong>Correct,</strong> aligns with AHA guidelines when PCI is not feasible within 120 minutes.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Option C:</strong> Start medical management with antiplatelet and anticoagulant agents only\r\n<ul>\r\n<li><strong>Incorrect,</strong> reperfusion therapy is necessary.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Option D:</strong> Administer nitrates and morphine, and observe\r\n<ul>\r\n<li><strong>Incorrect,</strong> delays reperfusion and increases myocardial damage.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Option E:</strong> Schedule PCI for the next day\r\n<ul>\r\n<li><strong>Incorrect,</strong> delays reperfusion beyond recommended time frames.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Contraindications to Fibrinolytic Therapy:</strong></p>\r\n<ul>\r\n<li><strong>Absolute Contraindications:</strong>\r\n<ul>\r\n<li>Active internal bleeding</li>\r\n<li>History of hemorrhagic stroke</li>\r\n<li>Recent intracranial or intraspinal surgery</li>\r\n<li>Severe uncontrolled hypertension</li>\r\n</ul>\r\n</li>\r\n<li><strong>Relative Contraindications:</strong>\r\n<ul>\r\n<li>Pregnancy</li>\r\n<li>Recent trauma</li>\r\n<li>Peptic ulcer disease</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Conclusion:</strong></p>\r\n<ul>\r\n<li>The patient requires urgent reperfusion.</li>\r\n<li><strong>Fibrinolytic therapy is indicated</strong> as PCI cannot be performed within 120 minutes.</li>\r\n<li>The patient has <strong>no contraindications</strong> to fibrinolytic therapy.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Administer fibrinolytic therapy</strong> when PCI is not available within 120 minutes of first medical contact.</li>\r\n<li><strong>Fibrinolytics should be given within 30 minutes</strong> of hospital arrival.</li>\r\n<li><strong>Time to reperfusion is critical;</strong> choose the fastest effective method available.</li>\r\n</ul>\r\n",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin alone</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin plus ticagrelor</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin plus clopidogrel</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin plus prasugrel</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 70-year-old man with a history of chronic kidney disease presents with an acute STEMI. He is scheduled for emergent PCI. According to the AHA guidelines, which antiplatelet therapy should be administered before the procedure to reduce the risk of stent thrombosis?</span></p>",
      "unique_key": "DT1295257",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295257,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Antiplatelet Therapy in STEMI Management:</strong></p>\r\n<ul>\r\n<li><strong>Dual Antiplatelet Therapy (DAPT):</strong>\r\n<ul>\r\n<li>Combination of aspirin and a P2Y12 receptor inhibitor</li>\r\n<li>Reduces the risk of stent thrombosis and adverse cardiovascular events</li>\r\n</ul>\r\n</li>\r\n<li><strong>P2Y12 Receptor Inhibitors:</strong>\r\n<ul>\r\n<li><strong>Clopidogrel</strong></li>\r\n<li><strong>Prasugrel</strong></li>\r\n<li><strong>Ticagrelor</strong></li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Considerations for P2Y12 Inhibitor Selection:</strong></p>\r\n<ul>\r\n<li><strong>Clopidogrel:</strong>\r\n<ul>\r\n<li>Prodrug requiring hepatic activation</li>\r\n<li>Variable response due to genetic polymorphisms</li>\r\n</ul>\r\n</li>\r\n<li><strong>Prasugrel:</strong>\r\n<ul>\r\n<li>Contraindicated in patients with a history of stroke or transient ischemic attack (TIA)</li>\r\n<li>Not recommended in patients &ge;75 years old or weighing &lt;60 kg due to bleeding risk</li>\r\n</ul>\r\n</li>\r\n<li><strong>Ticagrelor:</strong>\r\n<ul>\r\n<li>Direct-acting reversible inhibitor</li>\r\n<li>More potent and consistent platelet inhibition than clopidogrel</li>\r\n<li>Preferred in acute settings due to rapid onset</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Patient-Specific Factors:</strong></p>\r\n<ul>\r\n<li><strong>Age:</strong> 70 years old</li>\r\n<li><strong>Chronic Kidney Disease (CKD):</strong>\r\n<ul>\r\n<li>Prasugrel is used with caution in CKD</li>\r\n</ul>\r\n</li>\r\n<li><strong>AHA Guidelines Recommendations:</strong>\r\n<ul>\r\n<li><strong>Aspirin (Loading Dose):</strong> 162-325 mg</li>\r\n<li><strong>P2Y12 Inhibitor:</strong>\r\n<ul>\r\n<li><strong>Ticagrelor:</strong> Preferred due to rapid onset and efficacy</li>\r\n<li><strong>Prasugrel:</strong> Avoid in patients &ge;75 years old unless high-risk anatomy</li>\r\n<li><strong>Clopidogrel:</strong> Alternative if ticagrelor is contraindicated</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Table: Comparison of P2Y12 Inhibitors</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250107b22fa206-bb98-455a-8f4a-3a49ce421d0a.png\">\r\n<p><strong>Conclusion:</strong></p>\r\n<ul>\r\n<li><strong>Aspirin plus ticagrelor</strong> is the appropriate antiplatelet therapy for this patient scheduled for PCI.</li>\r\n<li>It provides effective platelet inhibition without the contraindications associated with prasugrel in elderly patients.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Dual antiplatelet therapy</strong> is essential in STEMI patients undergoing PCI.</li>\r\n<li><strong>Ticagrelor is preferred</strong> over clopidogrel due to greater efficacy and rapid onset.</li>\r\n<li><strong>Prasugrel is contraindicated</strong> in patients &ge;75 years old or with a history of stroke/TIA.</li>\r\n</ul>\r\n",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">High-intensity statin therapy</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Long-acting nitrate therapy</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous beta-blocker therapy</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Angiotensin-converting enzyme (ACE) inhibitor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old man presents with chest pain and is diagnosed with an anterior STEMI. He undergoes successful primary PCI with stent placement. According to AHA guidelines, which of the following medications should be started within 24 hours unless contraindicated?</span></p>",
      "unique_key": "DT1295260",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295260,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Post-MI Management According to AHA Guidelines:</strong></p>\r\n<ul>\r\n<li><strong>Medications to Initiate Post-MI:</strong>\r\n<ol>\r\n<li><strong>ACE Inhibitors:</strong>\r\n<ul>\r\n<li><strong>Indications:</strong>\r\n<ul>\r\n<li>Start within 24 hours in patients with:\r\n<ul>\r\n<li>Anterior MI</li>\r\n<li>Heart failure</li>\r\n<li>Left ventricular ejection fraction (LVEF) &le;40%</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li><strong>Benefits:</strong>\r\n<ul>\r\n<li>Reduce mortality</li>\r\n<li>Limit ventricular remodeling</li>\r\n<li>Decrease incidence of heart failure</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li><strong>Beta-Blockers:</strong>\r\n<ul>\r\n<li><strong>Oral beta-blockers</strong> should be started within 24 hours unless contraindicated.</li>\r\n<li><strong>Intravenous beta-blockers</strong> are reserved for hypertensive patients without signs of heart failure or cardiogenic shock.</li>\r\n</ul>\r\n</li>\r\n<li><strong>High-Intensity Statin Therapy:</strong>\r\n<ul>\r\n<li>Recommended for all patients post-MI regardless of baseline LDL levels.</li>\r\n</ul>\r\n</li>\r\n</ol>\r\n</li>\r\n<li><strong>Medications Not Routinely Started Immediately Post-MI:</strong>\r\n<ul>\r\n<li><strong>Long-Acting Nitrates:</strong>\r\n<ul>\r\n<li>Used for symptomatic relief of angina, not mandatory unless symptoms persist.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li><strong>Calcium Channel Blockers:</strong>\r\n<ul>\r\n<li>Not first-line post-MI unless beta-blockers are contraindicated.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Conclusion:</strong></p>\r\n<ul>\r\n<li>An <strong>ACE inhibitor</strong> should be initiated within 24 hours for this patient with an anterior STEMI to improve outcomes.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>ACE inhibitors</strong> reduce mortality and prevent ventricular remodeling post-MI.</li>\r\n<li><strong>Initiate within 24 hours</strong> in patients with anterior MI, heart failure, or LVEF &le;40%.</li>\r\n<li><strong>High-intensity statins</strong> are also important but ACE inhibitors are critical in the immediate post-MI period for certain patients.</li>\r\n</ul>\r\n",
      "correct_choice_id": 34,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Transthoracic echocardiography</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Magnetic resonance imaging (MRI)</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravascular ultrasound (IVUS)</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Computed tomography (CT) angiography</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the preferred imaging modality during PCI to assess the adequacy of stent placement?</span></p>",
      "unique_key": "DT1295264",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295264,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>1. Intravascular Ultrasound (IVUS):</strong></p>\r\n<ul>\r\n<li><strong>Function:</strong> IVUS is a specialized imaging tool that provides <strong>detailed cross-sectional images from within the artery.</strong></li>\r\n<li><strong>Benefits:</strong>\r\n<ul>\r\n<li>Allows real-time assessment of <strong>stent expansion, apposition</strong> (position of stent against the vessel wall), and <strong>arterial wall structure.</strong></li>\r\n<li>Improves <strong>stent deployment accuracy</strong> by ensuring proper expansion, which is critical to <strong>reduce risks of restenosis</strong> (narrowing due to tissue growth) and <strong>stent thrombosis.</strong></li>\r\n</ul>\r\n</li>\r\n<li><strong>Clinical Advantage:</strong> IVUS-guided PCI has been shown to improve outcomes by optimizing stent placement, which <strong>minimizes procedural complications.</strong></li>\r\n</ul>\r\n<p>2. <strong>Other Imaging Modalities:</strong></p>\r\n<ul>\r\n<li><strong>A. Transthoracic Echocardiography (TTE):</strong>\r\n<ul>\r\n<li><strong>Limitation:</strong> Lacks the <strong>resolution</strong> to visualize coronary arteries and stents directly.</li>\r\n<li><strong>Usage:</strong> Primarily used for <strong>cardiac structure and function</strong> assessment rather than intravascular visualization.</li>\r\n</ul>\r\n</li>\r\n<li><strong>B. Magnetic Resonance Imaging (MRI):</strong>\r\n<ul>\r\n<li><strong>Limitation:</strong> Not practical or recommended for acute coronary imaging or stent evaluation during PCI.</li>\r\n<li><strong>Usage:</strong> MRI provides valuable soft tissue imaging but does not offer the real-time, high-resolution detail necessary for PCI guidance.</li>\r\n</ul>\r\n</li>\r\n<li><strong>D. Computed Tomography (CT) Angiography:</strong>\r\n<ul>\r\n<li><strong>Limitation:</strong> CT angiography is often used <strong>pre-procedurally</strong> to assess coronary anatomy and plan interventions, but it is not feasible for real-time imaging during PCI.</li>\r\n<li><strong>Usage:</strong> Useful for non-invasive coronary artery assessment, but lacks practicality for in-procedure stent evaluation.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Intravascular Ultrasound (IVUS)</strong> is the preferred imaging tool during PCI, offering high-resolution intraluminal images for <strong>optimal stent expansion and positioning.</strong></li>\r\n<li><strong>Other imaging modalities</strong> (TTE, MRI, and CT angiography) do not provide the detail or real-time imaging capabilities required for in-procedure evaluation.</li>\r\n</ul>\r\n<p><strong>Clinical Guidelines:</strong></p>\r\n<ol>\r\n<li><strong>Utilize IVUS During PCI:</strong>\r\n<ul>\r\n<li>Use IVUS to assess stent expansion and apposition in real time to optimize PCI outcomes.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Understand When to Use Other Modalities:</strong>\r\n<ul>\r\n<li><strong>TTE:</strong> Primarily for cardiac structure, not coronary detail.</li>\r\n<li><strong>MRI:</strong> Limited use in acute coronary scenarios.</li>\r\n<li><strong>CT Angiography:</strong> Valuable pre-procedure but not practical during PCI.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Patient Education:</strong>\r\n<ul>\r\n<li>Explain the purpose of IVUS in ensuring precise stent placement and reducing long-term complications.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Consider IVUS or Optical Coherence Tomography (OCT):</strong>\r\n<ul>\r\n<li>OCT is an alternative to IVUS for high-resolution coronary imaging, though IVUS remains more widely used during PCI.</li>\r\n</ul>\r\n</li>\r\n</ol>\r\n",
      "correct_choice_id": 43,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Coronary artery spasm</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Coronary dissection</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">No-reflow phenomenon</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Restenosis of the stent</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">During PCI, a patient develops chest pain and ST-segment elevation in leads V1-V4. The most likely cause is:</span></p>",
      "unique_key": "DT1295267",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295267,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>1. <strong>Coronary Dissection:</strong></p>\r\n<ul>\r\n<li><strong>Definition:</strong> A <strong>coronary dissection</strong> involves a <strong>tear in the inner layer of the coronary artery,</strong> which can cause blood to pool within the artery wall, creating a false lumen that obstructs blood flow.</li>\r\n<li><strong>Mechanism:</strong> During PCI, instrumentation can lead to a tear in the vessel wall, particularly in areas with plaque or calcifications.</li>\r\n<li><strong>Symptoms:</strong> Coronary dissection leads to <strong>myocardial ischemia</strong> due to abrupt occlusion, causing <strong>chest pain</strong> and <strong>ST-segment elevation</strong> in leads corresponding to the affected area (e.g., V1-V4 for the anterior wall).</li>\r\n<li><strong>Severity:</strong> This is a serious complication of PCI, requiring <strong>immediate intervention</strong> such as stenting to seal the dissection or, in severe cases, urgent surgical repair.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250107f3d36d01-8881-4aa3-b629-52d054194344.jpg\">\r\n<p><strong>2. Differentiating from Other Causes:</strong></p>\r\n<ul>\r\n<li><strong>A. Coronary Artery Spasm:</strong>\r\n<ul>\r\n<li><strong>Description:</strong> Sudden, temporary constriction of the coronary artery can occur but is less <strong>common during PCI</strong> and typically transient.</li>\r\n<li><strong>Presentation:</strong> Although coronary spasm may cause ST-elevation, it generally resolves with nitro-glycerine and doesn't usually present with persistent ST-segment changes like dissection.</li>\r\n</ul>\r\n</li>\r\n<li><strong>C. No-Reflow Phenomenon:</strong>\r\n<ul>\r\n<li><strong>Description:</strong> The no-reflow phenomenon is due to <strong>microvascular obstruction</strong> (e.g., due to debris or thrombus) that limits blood flow after a PCI procedure.</li>\r\n<li><strong>Presentation:</strong> It causes <strong>reduced perfusion</strong> to the heart muscle but doesn't typically produce pronounced ST-segment elevation in specific leads; the ECG changes are often more subtle.</li>\r\n</ul>\r\n</li>\r\n<li><strong>D. Restenosis of the Stent:</strong>\r\n<ul>\r\n<li><strong>Description:</strong> Restenosis, or re-narrowing of the artery within the stent, typically develops <strong>weeks to months after PCI</strong> due to tissue overgrowth.</li>\r\n<li><strong>Presentation:</strong> It would not cause acute chest pain and ST-elevation during the procedure itself.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Coronary Dissection</strong> during PCI is a critical complication leading to <strong>acute ischemia</strong> and <strong>ST-segment elevation,</strong> requiring immediate intervention.</li>\r\n<li><strong>Other causes</strong> (spasm, no-reflow, and restenosis) may present differently or are less common during PCI itself.</li>\r\n</ul>\r\n<p><strong>Clinical Guidelines:</strong></p>\r\n<ol>\r\n<li><strong>Immediate Recognition and Intervention:</strong>\r\n<ul>\r\n<li>Rapid identification of ST-segment elevation and <strong>coronary dissection</strong> is essential for preventing myocardial damage.</li>\r\n<li>Intervention may include <strong>additional stenting</strong> or, in severe cases, urgent surgical repair.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Management of Other Possible Complications:</strong>\r\n<ul>\r\n<li><strong>Coronary Spasm:</strong> Treat with nitroglycerin and observe for resolution.</li>\r\n<li><strong>No-Reflow Phenomenon:</strong> Use vasodilators (e.g., adenosine or calcium channel blockers) and supportive measures.</li>\r\n<li><strong>Restenosis:</strong> Generally, this is a chronic issue, so follow-up and elective re-intervention may be considered if symptoms arise later.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Patient Monitoring Post-PCI:</strong>\r\n<ul>\r\n<li>Continuous <strong>ECG monitoring</strong> and assessment for <strong>chest pain</strong> or <strong>ST changes</strong> to detect complications early.</li>\r\n<li>Monitor for signs of ischemia and hemodynamic instability post-PCI, especially after addressing complications.</li>\r\n</ul>\r\n</li>\r\n</ol>\r\n",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypertensive urgency</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypertensive emergency</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic hypertension</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Malignant hypertension</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with long-standing hypertension presents with persistent headaches and visual disturbances. Fundoscopy reveals arteriolar narrowing, hemorrhages, and cotton wool spots. What is the likely diagnosis?</span></p>",
      "unique_key": "DT1295268",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295268,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>1. Malignant Hypertension Characteristics:</strong></p>\r\n<ul>\r\n<li><strong>Definition:</strong> Malignant hypertension is a severe form of hypertension characterized by <strong>markedly elevated blood pressure</strong> and<strong> end-organ damage,</strong> particularly in the retina, kidneys, brain, and heart.</li>\r\n<li><strong>Retinal Changes:</strong> The presence of <strong>retinal hemorrhages, cotton wool spots, and arteriolar narrowing</strong> on fundoscopy are hallmark signs of malignant hypertension. These findings indicate hypertensive retinopathy, a result of damage to retinal blood vessels due to persistently high blood pressure.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025010700babdd6-a8fa-4fc2-8eb3-021006570919.jpg\">\r\n<ul>\r\n<li><strong>Symptoms:</strong> Patients often experience <strong>headaches</strong> and <strong>visual disturbances</strong> due to increased intracranial pressure</li>\r\n</ul>\r\n<p><strong>2. Differentiation from Other Hypertensive Conditions:</strong></p>\r\n<ul>\r\n<li><strong>Hypertensive Urgency:</strong>\r\n<ul>\r\n<li>Involves severe <strong>hypertension</strong> (e.g., systolic BP &gt;180 mm Hg or diastolic BP &gt;120 mm Hg) <strong>without end-organ damage.</strong></li>\r\n<li>Symptoms may include headache but without retinal changes or other signs of organ damage.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Hypertensive Emergency:</strong>\r\n<ul>\r\n<li>Like malignant hypertension, hypertensive emergency includes <strong>severe hypertension with end-organ damage.</strong></li>\r\n<li>The distinction between hypertensive emergency and malignant hypertension often lies in <strong>specific end-organ involvement,</strong> with malignant hypertension specifically associated with severe retinal changes (e.g., <strong>hemorrhages and cotton wool spots</strong>).</li>\r\n</ul>\r\n</li>\r\n<li><strong>Chronic Hypertension:</strong>\r\n<ul>\r\n<li>Typically, <strong>asymptomatic</strong> or may present with mild symptoms.</li>\r\n<li>Retinal findings like hemorrhages and cotton wool spots are not common in chronic hypertension unless it progresses to a severe form (malignant hypertension).</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>3. Management of Malignant Hypertension:</strong></p>\r\n<ul>\r\n<li><strong>Immediate Intervention:</strong> Malignant hypertension requires <strong>urgent blood pressure reduction</strong> to prevent further end-organ damage.</li>\r\n<li><strong>IV Medications:</strong> Intravenous antihypertensives (e.g., labetalol, nitroprusside) may be necessary for rapid BP control in a controlled setting.</li>\r\n<li><strong>Monitoring:</strong> Patients often require hospitalization to monitor blood pressure and manage complications.</li>\r\n<li><strong>Long-Term Therapy:</strong> Once stabilized, oral antihypertensive therapy is initiated to maintain controlled blood pressure and prevent recurrence.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Malignant Hypertension</strong> is characterized by severe hypertension with <strong>end-organ damage.</strong></li>\r\n<li><strong>Retinal findings</strong> (e.g., hemorrhages, cotton wool spots) indicate <strong>hypertensive retinopathy</strong> and severe vascular damage.</li>\r\n<li><strong>Immediate treatment</strong> is critical to prevent irreversible damage to the retina, kidneys, brain, and heart.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Malignant hypertension requires immediate treatment to prevent irreversible end-organ damage.</li>\r\n<li>Retinal findings like hemorrhages and cotton wool spots indicate end-organ involvement.</li>\r\n</ul>\r\n",
      "correct_choice_id": 64,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Percutaneous angioplasty with stent placement</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Continue medical management alone</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Initiate dialysis</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Open surgical renal artery bypass</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old man with renal artery stenosis has worsening kidney function and uncontrolled hypertension despite medical therapy. What is the most appropriate next step in management?</span></p>",
      "unique_key": "DT1295269",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295269,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250107caacbadd-8257-40c5-ac61-5f453d701609.jpg\">\r\n<p>For patients with <strong>renal artery stenosis</strong> who have:</p>\r\n<ul>\r\n<li><strong>Progressive renal insufficiency</strong></li>\r\n<li><strong>Resistant hypertension</strong></li>\r\n</ul>\r\n<p><strong>Percutaneous angioplasty with stent placement</strong> is indicated because:</p>\r\n<ul>\r\n<li>It restores blood flow to the affected kidney.</li>\r\n<li>It can improve or stabilize renal function.</li>\r\n<li>It helps in better blood pressure control.</li>\r\n</ul>\r\n<p><strong>Continuing medical management</strong> is insufficient in the face of deteriorating kidney function. <strong>Dialysis</strong> may be necessary if renal failure progresses but doesn't address the underlying cause. <strong>Open surgical bypass</strong> is more invasive and typically considered when angioplasty is unsuccessful or not feasible.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Revascularization procedures</strong> are beneficial in selected patients with renal artery stenosis.</li>\r\n<li><strong>Percutaneous angioplasty</strong> is less invasive and has a shorter recovery time compared to open surgery.</li>\r\n<li>Early intervention can prevent irreversible kidney damage and improve hypertension control.</li>\r\n</ul>\r\n",
      "correct_choice_id": 71,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">D-dimer assay</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Duplex ultrasonography</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">CT venography</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Magnetic resonance imaging (MRI)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In a patient suspected of having a deep venous thrombosis (DVT) of the lower extremity, which is the most appropriate initial diagnostic test?</span></p>",
      "unique_key": "DT1295270",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295270,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>1. Duplex Ultrasonography: The Preferred Initial Test</strong></p>\r\n<ul>\r\n<li><strong>Description:</strong> Duplex ultrasonography combines <strong>traditional ultrasound</strong> with <strong>Doppler flow analysis,</strong> providing real-time imaging of blood flow and allowing detection of clots within the veins.</li>\r\n<li><strong>Reasons for First-Line Use:</strong>\r\n<ul>\r\n<li><strong>Non-Invasive:</strong> Duplex ultrasound is a <strong>non-invasive</strong> procedure, involving no injections or invasive procedures.</li>\r\n<li><strong>Wide Availability:</strong> It is <strong>commonly available</strong> in most medical centers and emergency departments, making it accessible and practical for initial evaluation.</li>\r\n<li>High Sensitivity and Specificity:\r\n<ul>\r\n<li>Particularly sensitive for detecting <strong>thrombi in the proximal veins</strong> (such as the femoral and popliteal veins).</li>\r\n<li>Sensitivity and specificity of duplex ultrasound for proximal DVT are approximately <strong>95-98%</strong> in symptomatic patients.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Cost-Effective:</strong> Compared to other imaging options, duplex ultrasound is <strong>less expensive</strong> and avoids the costs associated with advanced imaging modalities.</li>\r\n<li><strong>Radiation-Free:</strong> Unlike CT venography, it does not expose the patient to <strong>ionizing radiation,</strong> making it safer, especially for repeat evaluations or for use in pregnant patients.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>2. Alternative Imaging Modalities:</strong></p>\r\n<ul>\r\n<li><strong>A. D-Dimer Assay:</strong>\r\n<ul>\r\n<li><strong>Role:</strong> D-dimer is a <strong>blood test</strong> that measures fibrin degradation products, which are elevated in the presence of clot formation and breakdown.</li>\r\n<li><strong>Utility:</strong>\r\n<ul>\r\n<li>Useful as a <strong>rule-out test</strong> for patients with a low clinical probability of DVT.</li>\r\n<li>A negative D-dimer in conjunction with a low pre-test probability (based on Wells criteria or similar scoring systems) can effectively <strong>rule out DVT</strong> without further imaging.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li><strong>C. CT Venography:</strong>\r\n<ul>\r\n<li><strong>Description:</strong> CT venography is an imaging modality that provides detailed views of the venous system using contrast material.</li>\r\n<li><strong>Utility:</strong>\r\n<ul>\r\n<li>Primarily reserved for cases where <strong>ultrasound results are inconclusive</strong> or if <strong>DVT is suspected in regions</strong> difficult to visualize with ultrasound, such as <strong>pelvic veins.</strong></li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li><strong>D. Magnetic Resonance Imaging (MRI):</strong>\r\n<ul>\r\n<li><strong>Description:</strong> MRI can provide detailed images of blood vessels without ionizing radiation, particularly useful in complex cases.</li>\r\n<li><strong>Utility:</strong>\r\n<ul>\r\n<li>MRI is useful in detecting thrombi in regions <strong>not accessible by ultrasound,</strong> such as pelvic veins, or when <strong>CT venography is contraindicated.</strong></li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>3. Clinical Guidelines for DVT Diagnosis:</strong></p>\r\n<ul>\r\n<li><strong>Initial Evaluation:</strong>\r\n<ul>\r\n<li>For patients with suspected DVT based on symptoms (e.g., swelling, pain, warmth, or redness in one leg) and clinical assessment (e.g., Wells score), <strong>duplex ultrasound</strong> is the standard first diagnostic test.</li>\r\n</ul>\r\n</li>\r\n<li><strong>D-Dimer Use:</strong>\r\n<ul>\r\n<li>In patients with low <strong>pre-test probability</strong> of DVT, a <strong>negative D-dimer test</strong> can effectively rule out DVT, potentially avoiding the need for further imaging.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Advanced Imaging:</strong>\r\n<ul>\r\n<li><strong>CT Venography or MRI</strong> are considered if:\r\n<ul>\r\n<li>Duplex ultrasound results are <strong>inconclusive</strong>.</li>\r\n<li>DVT is suspected in areas where ultrasound has limited visualization, such as <strong>pelvic or iliac veins.</strong></li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Duplex ultrasonography</strong> is the gold standard for initial DVT evaluation.</li>\r\n<li><strong>D-dimer testing</strong> is helpful in conjunction with clinical assessment to rule out DVT.</li>\r\n<li>Advanced imaging is considered when ultrasound results are inconclusive.</li>\r\n</ul>\r\n",
      "correct_choice_id": 82,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic thromboembolic pulmonary hypertension (CTEPH)</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary pulmonary arterial hypertension</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary hypertension due to left heart disease</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary hypertension due to lung disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old woman with no significant past medical history presents with progressive dyspnea and fatigue. An echocardiogram reveals elevated pulmonary artery pressures. Which of the following is the most likely diagnosis?</span></p>",
      "unique_key": "DT1295271",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295271,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>1. Primary Pulmonary Arterial Hypertension (PAH):</strong></p>\r\n<ul>\r\n<li><strong>Definition:</strong> PAH is a type of <strong>idiopathic pulmonary hypertension</strong> that primarily affects the small pulmonary arteries, causing increased resistance and elevated pulmonary artery pressures.</li>\r\n<li><strong>Demographic:</strong> PAH most commonly affects <strong>young women</strong> and is often <strong>idiopathic</strong> (no known cause), though it may also have familial or genetic associations.</li>\r\n<li><strong>Symptoms:</strong>\r\n<ul>\r\n<li>Common presenting symptoms include <strong>dyspnea</strong> (shortness of breath) and <strong>fatigue,</strong> progressing gradually.</li>\r\n<li>Other potential symptoms include<strong> syncope</strong> (due to reduced cardiac output) and chest pain.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Diagnostic Features:</strong>\r\n<ul>\r\n<li><strong>Echocardiogram</strong> often shows <strong>elevated pulmonary pressures</strong> without evidence of left-sided heart disease or lung disease.</li>\r\n<li>Right heart catheterization may confirm the diagnosis by measuring increased pulmonary artery pressures and excluding other causes.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Importance of Early Diagnosis:</strong>\r\n<ul>\r\n<li><strong>Untreated PAH</strong> can lead to <strong>right ventricular hypertrophy</strong> and <strong>eventual right heart failure.</strong></li>\r\n<li>Early diagnosis is key to manage symptoms and prevent progression.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250107c51f3975-3d0e-4c9c-8087-aecbc3a1b121.png\">\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Primary Pulmonary Arterial Hypertension (PAH) </strong>is a<strong> diagnosis of exclusion</strong> in patients with pulmonary hypertension and no evidence of heart or lung disease.</li>\r\n<li><strong>Young females</strong> with symptoms of <strong>dyspnea, fatigue,</strong> and <strong>elevated pulmonary artery pressures</strong> are classic presentations for PAH.</li>\r\n<li><strong>Early recognition and treatment</strong> are critical to delay progression to <strong>right heart failure.</strong></li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>PAH is a diagnosis of exclusion and common in young females.</li>\r\n<li>Early diagnosis and management are crucial to prevent right heart failure.</li>\r\n</ul>\r\n",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Exclude pulmonary hypertension (PH)</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Diagnose isolated postcapillary pulmonary hypertension</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Measure pulmonary vascular resistance (PVR)</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Diagnose precapillary pulmonary hypertension</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old patient undergoes right heart catheterization due to symptoms of dyspnea on exertion. The measured mean pulmonary artery pressure (mPAP) is 25 mmHg, and pulmonary artery wedge pressure (PAWP) is 14 mmHg. What is the next best step in evaluating this patient?</span></p>",
      "unique_key": "DT1295272",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295272,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501073848fbbf-de89-4ce3-9ccd-25085a700a79.jpg\">\r\n<ul><li>According to the flowchart, if mPAP is above 20 mmHg (indicating elevated pulmonary pressure) and PAWP is &le;15 mmHg, the next step is to measure <strong>PVR</strong> to differentiate between precapillary and postcapillary forms of pulmonary hypertension.</li><li>A <strong>PVR &ge;3.0 WU</strong> would support a diagnosis of <strong>precapillary pulmonary hypertension</strong> (WHO Groups 1, 3, 4, or 5).</li><li>A <strong>PVR &lt;3.0 WU</strong> would lead to excluding pulmonary hypertension.</li></ul><p><strong>Key Takeaways:</strong></p><ul><li>Elevated mPAP with normal PAWP requires further assessment of PVR to confirm the type of pulmonary hypertension.</li><li>Right heart catheterization is the gold standard for pulmonary hypertension diagnosis and classification.</li></ul>",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Doppler ultrasound</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Ankle-brachial index (ABI)</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Magnetic resonance angiography (MRA)</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">CT angiography</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the most commonly used non-invasive test to confirm the diagnosis of peripheral artery disease?</span></p>",
      "unique_key": "DT1295273",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295273,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>1. Ankle-Brachial Index (ABI):</strong></p>\r\n<ul>\r\n<li><strong>Definition:</strong> The ABI test measures the ratio of <strong>blood pressure at the ankle</strong> to the <strong>blood pressure in the arm</strong> (brachial artery).</li>\r\n<li><strong>How It Works:</strong>\r\n<ul>\r\n<li>Blood pressure is taken at the <strong>brachial artery</strong> in the arm and at the <strong>posterior tibial and dorsalis pedis arteries</strong> in the ankle.</li>\r\n<li>The <strong>ABI value</strong> is calculated by dividing the systolic blood pressure at the ankle by the systolic blood pressure in the arm.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Interpretation:</strong>\r\n<ul>\r\n<li><strong>Normal ABI:</strong> 1.0&ndash;1.4 (suggests no significant arterial obstruction).</li>\r\n<li><strong>ABI &lt; 0.9:</strong> Indicates <strong>PAD.</strong></li>\r\n<li><strong>ABI &lt; 0.4:</strong> Suggests <strong>severe PAD</strong>, which may lead to critical limb ischemia.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Advantages:</strong>\r\n<ul>\r\n<li><strong>Simple and non-invasive:</strong> Only requires a blood pressure cuff and Doppler device.</li>\r\n<li><strong>Cost-effective:</strong> Inexpensive compared to advanced imaging tests.</li>\r\n<li><strong>High Sensitivity and Specificity:</strong> ABI is reliable for identifying PAD, especially in the lower extremities.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>2. Other Diagnostic Modalities:</strong></p>\r\n<ul>\r\n<li><strong>A. Doppler Ultrasound:</strong>\r\n<ul>\r\n<li><strong>Function:</strong> Measures <strong>blood flow</strong> and detects blockages in arteries by showing flow abnormalities.</li>\r\n<li><strong>Use:</strong> Often used as a follow-up tool to assess the severity of blockages or to localize lesions but is not a primary test for PAD.</li>\r\n</ul>\r\n</li>\r\n<li><strong>C. Magnetic Resonance Angiography (MRA):</strong>\r\n<ul>\r\n<li><strong>Function:</strong> Provides detailed images of blood vessels and can assess vessel <strong>structure and flow.</strong></li>\r\n<li><strong>Use:</strong> Commonly reserved for <strong>pre-surgical planning</strong> or complex cases, as it is more invasive and costly than ABI.</li>\r\n</ul>\r\n</li>\r\n<li><strong>D. CT Angiography:</strong>\r\n<ul>\r\n<li><strong>Function:</strong> Uses <strong>CT imaging and contrast dye</strong> to visualize arteries and detect obstructions.</li>\r\n<li><strong>Use:</strong> Primarily used for <strong>surgical or interventional planning;</strong> provides high-resolution images but involves <strong>radiation</strong> and contrast exposure, making it less ideal as an initial diagnostic test.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>ABI is a quick and cost-effective screening tool for PAD.</li>\r\n<li>A low ABI indicates significant arterial obstruction.</li>\r\n</ul>\r\n",
      "correct_choice_id": 112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\"><1.5 cm2</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\"><1.0 cm2</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\"><1.0 cm2/m2 of body surface area </span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\"><1.50 cm2/m2 of body surface area</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In adults' Severe aortic stenosis is defined as aortic valve area of?</span></p>",
      "unique_key": "DT1295274",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295274,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Severe Aortic Stenosis (AS):</strong>\r\n<ul>\r\n<li>Defined by a <strong>valve area &lt;1.0 cm&sup2;.</strong></li>\r\n<li><strong>Moderate AS:</strong> valve area <strong>1.0-1.5 cm&sup2;.</strong></li>\r\n<li><strong>Mild AS:</strong> valve area <strong>1.5-2.0 cm&sup2;.</strong></li>\r\n</ul>\r\n</li>\r\n<li><strong>Aortic Valve Sclerosis:</strong>\r\n<ul>\r\n<li>Associated with a jet velocity of <strong>&lt;2.5 m/s.</strong></li>\r\n</ul>\r\n</li>\r\n<li><strong>Diagnosis:</strong>\r\n<ul>\r\n<li><strong>Doppler echocardiography</strong> is essential for estimating valve gradient and area.</li>\r\n<li>A <strong>high transvalvular gradient</strong> often indicates severe obstruction.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Clinical Findings:</strong>\r\n<ul>\r\n<li><strong>Pulsus parvus et tardus:</strong></li>\r\n</ul>\r\n</li>\r\n<li>Characterized by a <strong>slow-rising carotid pulse</strong> with a delayed peak.\r\n<ul>\r\n<li><strong>Auscultation:</strong></li>\r\n</ul>\r\n</li>\r\n<li>A <strong>systolic ejection murmur:</strong> low-pitched, rough, loudest at the second right intercostal space.</li>\r\n<li>Murmur often transmitted to the carotids, may confuse with mitral regurgitation <strong>(Gallavardin effect).</strong></li>\r\n<li><strong>Symptoms of Severe AS:</strong>\r\n<ul>\r\n<li><strong>Cardinal Symptoms:</strong></li>\r\n</ul>\r\n</li>\r\n<li><strong>Exertional dyspnea:</strong> Difficulty breathing during activity.</li>\r\n<li><strong>Angina pectoris:</strong> Chest pain due to reduced coronary perfusion.</li>\r\n<li><strong>Syncope:</strong> Dizziness or fainting from reduced cardiac output.</li>\r\n<li><strong>Impairment of Left Ventricular (LV) Function:</strong>\r\n<ul>\r\n<li><strong>LV dilation</strong> and<strong> reduced systolic function</strong> may occur as AS progresses.</li>\r\n<li>Patients may present with a <strong>low-flow, low-gradient severe AS</strong> even with a normal ejection fraction.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Option A (&lt;1.5 cm&sup2;):</strong> This indicates moderate AS; not sufficient for severe classification.</li>\r\n<li><strong>Option C (&lt;1.0 cm&sup2;/m&sup2;):</strong> Incorrect as the measurement unit is misapplied; area must be in cm&sup2; alone.</li>\r\n<li><strong>Option D (&lt;1.50 cm&sup2;/m&sup2;):</strong> Indicates moderate AS, which does not align with the definition of severe AS.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Severe aortic stenosis is critically defined by a <strong>valve area &lt;1.0 cm&sup2;.</strong></li>\r\n<li>Recognizing the severity is essential for timely intervention, particularly regarding <strong>valve replacement,</strong> to improve patient outcomes.</li>\r\n</ul>\r\n",
      "correct_choice_id": 122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Surgical Aortic valve replacement (SAVR)</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Transaortic valve replacement (TAVI)</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">SAVR in patients younger than 50 years and TAVI in patients elder than 50 years.</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Optimum medical therapy with Follow up of the patient with 6 monthly echocardiography </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the preferred mode of therapy of a patient of symptomatic severe aortic stenosis with aortic arch aneurysm>5.5 cm?</span></p>",
      "unique_key": "DT1295275",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295275,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Indications for Surgery:</strong>\r\n<ul>\r\n<li><strong>Symptomatic severe aortic stenosis (AS):</strong> Valve area &lt;1.0 cm&sup2; or 0.6 cm&sup2;/m&sup2; body surface area.</li>\r\n<li><strong>LV systolic dysfunction: EF &lt;50%.</strong></li>\r\n<li><strong>Aortic arch aneurysm:</strong> Recommended surgical intervention when the maximum diameter exceeds 5.5 cm.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Surgical Aortic Valve Replacement (SAVR):</strong>\r\n<ul>\r\n<li>Preferred in cases of <strong>symptomatic AS</strong> with significant comorbidities (e.g., aneurysm).</li>\r\n<li>Provides definitive treatment for both the valve and associated aneurysm.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Transcatheter Aortic Valve Replacement (TAVI):</strong>\r\n<ul>\r\n<li>Typically reserved for high-risk surgical candidates, especially in <strong>low-gradient severe AS</strong> cases.</li>\r\n<li>Not preferred for patients with significant anatomical issues like an aortic arch aneurysm.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Patient Management:</strong>\r\n<ul>\r\n<li><strong>Bio prosthetic valves</strong> are favored for patients &gt;65 years; mechanical valves preferred for those &lt;50 years.</li>\r\n<li>Patients with severe AS and significant symptoms face increased <strong>perioperative mortality rates (15-20%).</strong></li>\r\n</ul>\r\n</li>\r\n<li><strong>Risks and Considerations:</strong>\r\n<ul>\r\n<li><strong>SAVR</strong> is critical for patients at risk of rapid aneurysm growth (&gt;0.5 cm/year) or with a family history of aortic catastrophes.</li>\r\n<li>Medical management alone is inadequate for symptomatic severe AS.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Option B (TAVI):</strong> Not indicated due to significant associated aneurysm; SAVR is more appropriate for simultaneous treatment.</li>\r\n<li><strong>Option C:</strong> Misleading, as it suggests age-based treatment differentiation which is not supported by the clinical scenario.</li>\r\n<li><strong>Option D:</strong> Medical therapy alone is ineffective for symptomatic severe AS; surgical intervention is necessary.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>The optimal therapy for symptomatic severe aortic stenosis with an aortic arch aneurysm &gt;5.5 cm is <strong>SAVR.</strong></li>\r\n<li>Timely intervention is crucial to reduce mortality and improve outcomes, particularly in symptomatic patients with complex conditions.</li>\r\n</ul>\r\n",
      "correct_choice_id": 131,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">High procedural surgical risk with AVR</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Age of the patient>65 years </span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Contraindication to use vitamin K antagonist.</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is indication for transcatheter aortic valve implantation over surgical aortic valve replacement (AVR) for management of symptomatic severe aortic stenosis?</span></p>",
      "unique_key": "DT1295276",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295276,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Transcatheter Aortic Valve Implantation (TAVI) vs. Surgical Aortic Valve Replacement (AVR)</strong></p>\r\n<ul>\r\n<li><strong>Indication for TAVI:</strong>\r\n<ul>\r\n<li><strong>High Procedural Surgical Risk with AVR:</strong> TAVI is preferred in patients with a <strong>perioperative risk &gt;8%,</strong> especially in cases of low flow and poor left ventricular (LV) systolic function.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Age Considerations:</strong>\r\n<ul>\r\n<li>While age &gt;65 years is a factor in decision-making, it alone does not justify the use of TAVI over SAVR.</li>\r\n<li>For patients over <strong>80 years,</strong> TAVI may be considered, but age alone is not a definitive indicator.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Contraindications:</strong>\r\n<ul>\r\n<li>A contraindication to using a vitamin K antagonist may influence the choice of valve type but does not automatically indicate TAVI over SAVR. The overall clinical context is critical.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Comparison of TAVI and SAVR:</strong>\r\n<ul>\r\n<li><strong>TAVI Advantages:</strong>\r\n<ul>\r\n<li>Fewer periprocedural deaths, lower stroke rates, and decreased major bleeding risks compared to SAVR.</li>\r\n<li>Shorter hospital stays and faster return to normal activity.</li>\r\n</ul>\r\n</li>\r\n<li><strong>SAVR Advantages:</strong>\r\n<ul>\r\n<li>Lower rates of permanent pacemaker usage, peri-valvular aortic regurgitation (AR), and vascular complications.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Option B (Age &gt;65 years):</strong> Incorrect; age alone does not dictate TAVI over SAVR.</li>\r\n<li><strong>Option C (Contraindication to vitamin K antagonist):</strong> Incorrect; while this may affect anticoagulation management, it is not a standalone indication for TAVI.</li>\r\n<li><strong>Option D (All of the above):</strong> Incorrect; because not all the listed options are valid indications for TAVI.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>TAVI</strong> is indicated for patients with <strong>high procedural surgical risk</strong> for AVR, particularly in the context of severe symptomatic aortic stenosis.</li>\r\n<li>Understanding the specific clinical context is essential in determining the most appropriate intervention, balancing risks and benefits for the patient.</li>\r\n</ul>\r\n",
      "correct_choice_id": 141,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Severe acute Aortic regurgitation.</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Severe Aortic regurgitation with aortic stenosis</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Severe chronic aortic regurgitation </span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Severe Mitral regurgitation.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Austin Flint murmur is seen in which of the following condition?</span></p>",
      "unique_key": "DT1295277",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295277,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Austin Flint Murmur Characteristics:</strong>\r\n<ul>\r\n<li>A<strong> soft, low-pitched, rumbling mid-to-late diastolic murmur.</strong></li>\r\n<li>Caused by the<strong> diastolic displacement of the anterior leaflet of the mitral valve</strong> due to the regurgitant flow from aortic regurgitation (AR).</li>\r\n<li>Not associated with <strong>hemodynamically significant mitral valve obstruction.</strong></li>\r\n</ul>\r\n</li>\r\n<li><strong>Conditions Associated:</strong>\r\n<ul>\r\n<li><strong>Chronic Aortic Regurgitation:</strong> Commonly associated with Austin Flint murmur due to prolonged volume overload leading to changes in the mitral valve dynamics.</li>\r\n<li><strong>Acute Aortic Regurgitation:</strong> Does not typically produce this murmur; presents with more acute and severe symptoms without the chronic adaptations seen in severe chronic AR.</li>\r\n<li><strong>Aortic Stenosis with AR:</strong> Although both conditions may coexist, the murmur is specifically indicative of chronic AR.</li>\r\n<li><strong>Mitral Regurgitation:</strong> Austin Flint murmur is not related to this condition.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250107c0148618-949c-4214-b182-365c382879b5.jpg\">\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Option A (Severe acute AR):</strong> Incorrect; acute AR does not produce Austin Flint murmur.</li>\r\n<li><strong>Option B (Severe AR with aortic stenosis):</strong> Incorrect; this murmur is specific to chronic AR.</li>\r\n<li><strong>Option D (Severe mitral regurgitation):</strong> Incorrect; the murmur is not associated with mitral regurgitation.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>The<strong> Austin Flint murmur</strong> is indicative of <strong>severe chronic aortic regurgitation,</strong> arising from altered mitral valve dynamics due to diastolic displacement.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501077342deaa-5c18-44ff-be1b-31895ab400bf.jpg\">\r\n<ul>\r\n<li>Recognizing the distinguishing features of acute vs. chronic AR is essential for accurate diagnosis and management.</li>\r\n</ul>\r\n",
      "correct_choice_id": 153,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Intraaortic balloon counter pulsation </span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">b-blockers </span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Sodium nitroprusside </span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Both A and C </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following modalities of therapy should be used in the management of acute severe AR?</span></p>",
      "unique_key": "DT1295278",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295278,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Management of Acute Severe AR:</strong>\r\n<ul>\r\n<li><strong>Intravenous Diuretics and Vasodilators:</strong> Patients may respond to medications like <strong>sodium nitroprusside,</strong> which reduces systemic vascular resistance and helps alleviate heart strain.</li>\r\n<li><strong>Surgical Intervention: Urgent surgery</strong> is typically required, often within <strong>24 hours</strong> of diagnosis, to manage the underlying cause effectively.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Contraindications and Considerations:</strong>\r\n<ul>\r\n<li><strong>Intra-aortic Balloon Counterpulsation (IABP): Contraindicated</strong> in acute severe AR due to potential worsening of regurgitation and left ventricular (LV) dysfunction.</li>\r\n<li><strong>Beta-blockers: </strong>Should be<strong> avoided</strong> as they can further reduce cardiac output and prolong diastolic filling time, which is critical in acute settings.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Must-Know Facts about Chronic Severe AR Management:</strong></p>\r\n<ul>\r\n<li><strong>Symptom Onset:</strong> The presence of symptoms or LV systolic dysfunction indicates a need for surgical intervention.</li>\r\n<li><strong>Temporary Medical Treatment:</strong>\r\n<ul>\r\n<li>Diuretics and <strong>vasodilators</strong> (like ACE inhibitors or ARBs) can serve as short-term measures.</li>\r\n<li><strong>Nitroglycerin</strong> may provide some relief for angina, although it's less effective than in coronary artery disease.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Aortic Valve Replacement (AVR):</strong> Indicated in <strong>symptomatic</strong> patients regardless of LV function.</li>\r\n<li><strong>TAVI Consideration:</strong> Not recommended for surgical candidates with severe AR.</li>\r\n<li>Surgical Criteria: Indicated in asymptomatic patients with <strong>progressive LV dysfunction</strong> (LVEF &lt;55% or specific LV dimensions).</li>\r\n<li><strong>Follow-Up:</strong> Patients without surgical indications should undergo clinical and echocardiographic evaluations every <strong>6&ndash;12 months.</strong></li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Option A (Intra-aortic balloon counterpulsation):</strong> Incorrect; can worsen the condition in acute AR.</li>\r\n<li><strong>Option B (Beta-blockers):</strong> Incorrect; they can decrease cardiac output and worsen diastolic filling.</li>\r\n<li><strong>Option D (Both A and C):</strong> Incorrect; A is contraindicated in acute severe AR.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Sodium nitroprusside</strong> is the preferred initial therapy for managing acute severe aortic regurgitation, aimed at stabilization before urgent surgical intervention.</li>\r\n<li>Understanding the contraindications and urgent need for surgical management is crucial for effective treatment of acute severe AR.</li>\r\n</ul>\r\n",
      "correct_choice_id": 163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Longer gap between second heart sound and Opening snap.</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Long duration of diastolic murmur </span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitral orifice area <2.0 </span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a feature of severe MS?</span></p>",
      "unique_key": "DT1295279",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295279,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Opening Snap (OS):</strong>\r\n<ul>\r\n<li><strong>Audible during Expiration:</strong> The OS occurs shortly after the second heart sound (A2) by <strong>0.05-0.12 seconds.</strong></li>\r\n<li><strong>Inversely Related to Severity:</strong> In severe mitral stenosis, the time interval between A2 and OS <strong>decreases,</strong> not increases.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Diastolic Murmur Duration:</strong>\r\n<ul>\r\n<li><strong>Long Duration:</strong> In severe MS, the duration of the diastolic murmur is<strong> longer</strong> due to increased turbulence as blood flows through the narrowed mitral orifice.</li>\r\n<li><strong>Best Heard at Apex:</strong> This murmur is typically low-pitched and rumbling, accentuated during <strong>atrial systole</strong> in sinus rhythm.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Mitral Orifice Area:</strong>\r\n<ul>\r\n<li><strong>Critical Measurement:</strong> In severe MS, the mitral valve orifice area is typically <strong>&lt;2.0 cm&sup2;</strong> (with severe being 1-1.5 cm&sup2; and very severe &lt;1 cm&sup2;).</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Must-Know Facts about Mitral Stenosis:</strong></p>\r\n<ul>\r\n<li><strong>Causes:</strong> Most commonly caused by <strong>rheumatic fever,</strong> but can also result from congenital defects, severe mitral annular calcification, systemic lupus erythematosus, or myxomas.</li>\r\n<li><strong>Pathophysiology:</strong> Chronic inflammation leads to <strong>thickening</strong> and <strong>calcification</strong> of the valve leaflets, which narrows the valve opening, often described as a \"fish-mouth\" appearance.</li>\r\n<li><strong>Symptoms:</strong> Common symptoms include <strong>exertional dyspnea, hemoptysis,</strong> and <strong>recurrent pulmonary emboli.</strong></li>\r\n<li><strong>Important JVP Waves:</strong>\r\n<ul>\r\n<li><strong>Prominent A wave:</strong> Indicates pulmonary hypertension.</li>\r\n<li><strong>Absent A wave:</strong> Suggests atrial fibrillation.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Examination Findings in Mitral Stenosis:</strong></p>\r\n<ul>\r\n<li><strong>Diastolic Thrill</strong> at the apex.</li>\r\n<li><strong>Increased Intensity of First Heart Sound (S1).</strong></li>\r\n<li><strong>Loud P2</strong> if pulmonary artery pressure is elevated.</li>\r\n<li><strong>Opening Snap</strong> is a characteristic sound.</li>\r\n<li><strong>Mid-Diastolic Murmur </strong>with<strong> presystolic accentuation</strong> in patients with sinus rhythm.</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Option B (Long duration of diastolic murmur):</strong> Incorrect; this is a characteristic feature of severe MS.</li>\r\n<li><strong>Option C (Mitral orifice area &lt;2.0):</strong> Incorrect; severe MS is defined by a mitral orifice area &lt;2.0 cm&sup2;.</li>\r\n<li><strong>Option D (All of the above):</strong> Incorrect; only option A is not a feature of severe MS.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>The <strong>longer gap</strong> between A2 and OS is <strong>not a feature</strong> of severe mitral stenosis; it is usually shorter due to increased severity.</li>\r\n<li>Understanding the characteristics of MS is crucial for accurate diagnosis and management of this valvular heart disease.</li>\r\n</ul>\r\n",
      "correct_choice_id": 171,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Percutaneous mitral balloon commissurotomy.</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitral valve replacement </span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitral balloon commissurotomy. </span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">BOTH A and C can be done depending on age.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is preferred mode of therapy for a case of severe symptomatic MS with nonpliable mitral valve and associated severe mitral regurgitation?</span></p>",
      "unique_key": "DT1295280",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295280,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Mitral Valve Replacement (MVR):</strong>\r\n<ul>\r\n<li><strong>Indication:</strong> Necessary for patients with severe MS and <strong>significant mitral regurgitation (MR)</strong>, especially if the valve is nonpliable or distorted.</li>\r\n<li><strong>Criteria:</strong> MVR is indicated when previous interventions do not improve valve function significantly or if the valve cannot be effectively treated with commissurotomy.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Percutaneous Mitral Balloon Commissurotomy:</strong>\r\n<ul>\r\n<li><strong>Not Preferred Here:</strong> While this procedure is useful for symptomatic patients with isolated severe MS, it requires <strong>pliable leaflets</strong> and minimal calcium.</li>\r\n<li><strong>Requirements:</strong> Ideal candidates for this procedure have <strong>no significant MR, </strong>with<strong> leaflets that are not severely scarred or thickened.</strong></li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Good to Know:</strong></p>\r\n<ul>\r\n<li><strong>Echo Score:</strong> Assessment of mitral valve leaflets&rsquo; thickness, calcification, mobility, and sub-valvular structures aids in deciding between percutaneous and surgical commissurotomy.</li>\r\n<li><strong>Success Criteria:</strong> Successful commissurotomy results in:\r\n<ul>\r\n<li><strong>50% reduction</strong> in mean mitral valve gradient.</li>\r\n<li><strong>Doubling</strong> of mitral valve area.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Symptomatic Improvement:</strong> Successful procedures lead to significant <strong>symptomatic and hemodynamic improvement.</strong></li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Option A (Percutaneous mitral balloon commissurotomy):</strong> Incorrect; unsuitable for nonpliable valves with severe MR.</li>\r\n<li><strong>Option C (Mitral balloon commissurotomy):</strong> Incorrect; similar to option A, it is not appropriate for this case.</li>\r\n<li><strong>Option D (Both A and C):</strong> Incorrect; neither procedure is appropriate given the patient's condition.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Mitral valve replacement </strong>is the<strong> preferred therapy</strong> for severe symptomatic MS with a nonpliable valve and significant MR.</li>\r\n<li>Understanding the appropriate interventions for mitral stenosis is crucial for optimal patient management and outcomes.</li>\r\n</ul>\r\n",
      "correct_choice_id": 182,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiac catheterisation  </span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiac MRI</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Transoesophageal echocardiography</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Transthoracic echocardiography</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is investigation of choice to make the diagnosis mitral valve prolapse?</span></p>",
      "unique_key": "DT1295281",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295281,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Transthoracic Echocardiography (TTE):</strong>\r\n<ul>\r\n<li><strong>Role:</strong> The primary and most effective imaging technique for identifying the abnormal position and prolapse of the mitral valve leaflets.</li>\r\n<li><strong>Diagnosis Criteria:</strong> Defined by at least <strong>2 mm systolic displacement</strong> of the mitral valve leaflets into the left atrium above the mitral annulus plane.</li>\r\n<li><strong>Assessment:</strong> Color flow and continuous wave Doppler imaging are essential for evaluating associated mitral regurgitation (MR) and estimating its severity.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Other Imaging Techniques:</strong>\r\n<ul>\r\n<li><strong>Transoesophageal Echocardiography (TEE):</strong> Used for more detailed anatomical information, especially during surgical interventions, but not the first-line choice for diagnosis.</li>\r\n<li><strong>Cardiac MRI:</strong> Helpful for precise LV volume measurements but not necessary for initial MVP diagnosis.</li>\r\n<li><strong>Cardiac Catheterization:</strong> Not indicated for diagnosing MVP.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Option A (Cardiac catheterization):</strong> Incorrect; invasive and not suitable for MVP diagnosis.</li>\r\n<li><strong>Option B (Cardiac MRI):</strong> Incorrect; while useful, it is not the first-line investigation for MVP.</li>\r\n<li><strong>Option C (Transoesophageal echocardiography):</strong> Incorrect; reserved for cases needing more detail, not the primary investigation.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Transthoracic echocardiography (TTE) </strong>is the<strong> investigation of choice</strong> for diagnosing mitral valve prolapse due to its effectiveness in visualizing valve displacement and associated conditions.</li>\r\n<li>MVP is linked to connective tissue disorders and is a significant cause of primary mitral regurgitation, making accurate diagnosis crucial for management.</li>\r\n</ul>\r\n",
      "correct_choice_id": 194,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic severe Mitral regurgitation (MR)</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute severe MR</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic severe MR with mitral stenosis </span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic severe AR</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 34 years old female presents with palpitation, exertional dyspnoea and orthopnoea. The symptoms have been progressive. Examination shows tachycardia, hyperdynamic inferolaterally displaced Apex, grade 3 holosystolic murmur at apex with radiation towards left sternal border and a short mid-diastolic rumbling murmur in the apex without presystolic accentuation. What is the most likely diagnosis? </span></p>",
      "unique_key": "DT1295282",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295282,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Transthoracic Echocardiography (TTE):</strong>\r\n<ul>\r\n<li><strong>Role:</strong> The primary and most effective imaging technique for identifying the abnormal position and prolapse of the mitral valve leaflets.</li>\r\n<li><strong>Diagnosis Criteria:</strong> Defined by at least <strong>2 mm systolic displacement</strong> of the mitral valve leaflets into the left atrium above the mitral annulus plane.</li>\r\n<li><strong>Assessment:</strong> Color flow and continuous wave Doppler imaging are essential for evaluating associated mitral regurgitation (MR) and estimating its severity.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Other Imaging Techniques:</strong>\r\n<ul>\r\n<li><strong>Transoesophageal Echocardiography (TEE):</strong> Used for more detailed anatomical information, especially during surgical interventions, but not the first-line choice for diagnosis.</li>\r\n<li><strong>Cardiac MRI:</strong> Helpful for precise LV volume measurements but not necessary for initial MVP diagnosis.</li>\r\n<li><strong>Cardiac Catheterization:</strong> Not indicated for diagnosing MVP.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Option A (Cardiac catheterization):</strong> Incorrect; invasive and not suitable for MVP diagnosis.</li>\r\n<li><strong>Option B (Cardiac MRI):</strong> Incorrect; while useful, it is not the first-line investigation for MVP.</li>\r\n<li><strong>Option C (Transoesophageal echocardiography):</strong> Incorrect; reserved for cases needing more detail, not the primary investigation.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Transthoracic echocardiography (TTE) </strong>is the<strong> investigation of choice</strong> for diagnosing mitral valve prolapse due to its effectiveness in visualizing valve displacement and associated conditions.</li>\r\n<li>MVP is linked to connective tissue disorders and is a significant cause of primary mitral regurgitation, making accurate diagnosis crucial for management.&nbsp;</li>\r\n</ul>\r\n",
      "correct_choice_id": 201,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Squatting</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Isometric exercise </span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Strain phase of Valsalva maneuver.</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">With which of the following maneuvers the murmur and ejection click of mitral valve prolapse occurs earlier in the systole?</span></p>",
      "unique_key": "DT1295283",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295283,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Strain Phase of Valsalva Maneuver:</strong>\r\n<ul>\r\n<li><strong>Effect:</strong> Reduces left ventricular (LV) volume (preload), leading to an earlier onset of the click and murmur due to increased leaflet prolapse propensity.</li>\r\n<li><strong>Timing:</strong> The murmur and click occur sooner in the cardiac cycle.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Other Maneuvers:</strong>\r\n<ul>\r\n<li><strong>Squatting:</strong> Increases LV volume, which delays the click-murmur complex and may even cause it to disappear.</li>\r\n<li><strong>Isometric Exercise:</strong> Also increases LV volume, having a similar effect as squatting.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Option A (Squatting):</strong> Incorrect; this maneuver increases preload, delaying the click and murmur.</li>\r\n<li><strong>Option B (Isometric exercise):</strong> Incorrect; like squatting, it increases LV volume, causing a delay in the click-murmur complex.</li>\r\n<li><strong>Option D (All of the above):</strong> Incorrect; since only the strain phase of Valsalva causes an earlier click and murmur.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>The <strong>strain phase of the Valsalva maneuver</strong> causes the murmur and ejection click of mitral valve prolapse to occur <strong>earlier in systole</strong> due to decreased LV volume.</li>\r\n<li>Understanding these dynamics helps in the assessment and management of patients with mitral valve prolapse, especially during physical activities.</li>\r\n</ul>\r\n",
      "correct_choice_id": 213,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}